疫苗注射設備市場規模、佔有率和成長分析（按設備類型、給藥途徑、最終用戶和地區）- 2025-2032 年產業預測

2023 年疫苗輸送裝置市場規模價值 67.7 億美元，預計將從 2024 年的 73.3 億美元成長到 2032 年的 138.8 億美元，預測期內（2025-2032 年）的複合年成長率為 8.3%。

受疫苗接種舉措不斷增加和對高效給藥方法的需求的推動，全球疫苗輸送設備市場正在經歷強勁成長。主要促進因素包括疫苗接種計劃的擴大、針頭技術的進步以及預防保健意識的增強。這凸顯了可靠低溫運輸的重要性，尤其是在缺乏足夠冷藏設施的地區。自動停用針筒和預填充式注射器系統等輸送裝置的最新創新提高了安全性和有效性。目前，北美和歐洲引領市場，但亞太地區具有巨大的成長潛力。隨著疫苗需求的激增，市場將朝著創新、易於使用且具成本效益的輸送解決方案的方向發展。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析
• 技術分析

疫苗注射設備市場規模（按設備類型和複合年成長率） (2025-2032)

• 市場概況
• 無針注射系統
• 口服給藥系統
• 鼻腔給藥系統
• 噴射注射器
• 微針貼片
• 微量注射器

疫苗注射裝置市場規模（按注射途徑和複合年成長率） (2025-2032)

• 市場概況
• 皮內接種
• 肌肉注射
• 皮下接種
• 其他疫苗接種

疫苗注射裝置市場規模（按最終用戶和複合年成長率分類）（2025-2032 年）

• 市場概況
• 醫院
• 診所
• 其他最終用戶

疫苗注射裝置市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Becton Dickinson & Company（USA）
• Bioject Medical Technologies, Inc.（USA）
• Inovio Pharmaceuticals, Inc.（USA）
• PharmaJet（USA）
• Vaxxas（Australia）
• Gerresheimer AG（Germany）
• SCHOTT AG（Germany）
• Corium International, Inc.（USA）
• 3M（USA）
• West Pharmaceutical Services, Inc.（USA）
• Terumo Corporation（Japan）
• B. Braun Melsungen AG（Germany）
• Smiths Medical（UK）
• Medtronic（Ireland）
• Sanofi Pasteur（France）
• Novartis AG（Switzerland）
• Pfizer Inc.（USA）
• GlaxoSmithKline plc（UK）
• Merck & Co., Inc.（USA）
• Johnson & Johnson（USA）

結論和建議

Vaccine Delivery Devices Market size was valued at USD 6.77 billion in 2023 and is poised to grow from USD 7.33 billion in 2024 to USD 13.88 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global vaccine delivery devices market is experiencing robust growth, fueled by increased vaccination initiatives and the demand for efficient administration methods. Key drivers include the expansion of immunization programs, advancements in needle technology, and heightened awareness of preventive healthcare. A crucial concern remains the integrity of vaccines during storage and transport, emphasizing the importance of a reliable cold chain, particularly in areas lacking proper refrigeration. Recent innovations in delivery devices, including auto-disable syringes and prefilled syringe systems, enhance safety and efficacy. While North America and Europe currently lead the market, the Asia-Pacific region shows significant growth potential. As vaccine demand surges, the market is poised for evolution with an emphasis on innovative, user-friendly, and cost-effective delivery solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vaccine Delivery Devices Market Segments Analysis

Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vaccine Delivery Devices Market

The increasing demand for vaccines, fueled by continuous initiatives aimed at tackling infectious diseases like COVID-19 and various preventable illnesses, has created a significant driver for the vaccine delivery devices market. As global health efforts intensify, the necessity for efficient and reliable delivery systems becomes paramount to guarantee proper immunization. This surge in vaccine production and distribution emphasizes the critical role that advanced delivery devices play in enhancing vaccination rates and ensuring the effectiveness of immunization programs. Consequently, the growth of the vaccine delivery devices market is closely linked to the rising urgency for innovative solutions that meet the needs of public health initiatives.

Restraints in the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market faces significant constraints due to the high costs associated with developing and manufacturing advanced technologies. The extensive research and development required can lead to substantial expenses, which are often transferred to end-users such as healthcare facilities and patients. This financial burden can hinder the widespread adoption of these innovative devices, especially in resource-limited environments. Consequently, the cost-related barriers may restrict access in certain regions, preventing the full realization of the benefits that these advanced vaccine delivery solutions can offer in enhancing immunization efforts and overall public health outcomes.

Market Trends of the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is witnessing a notable trend towards innovations in needle-free delivery systems, which are rapidly gaining traction among healthcare providers and patients alike. These advanced technologies, including jet injectors, microneedle patches, and nasal sprays, address common concerns associated with traditional needle-based vaccinations, such as anxiety and needle-stick injuries. By offering alternative delivery methods, these innovations not only enhance patient compliance but also improve vaccine stability and efficacy. As vaccination campaigns become increasingly critical, the shift towards needle-free solutions is expected to drive market growth, enhance operational efficiencies, and transform the overall vaccination experience.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2025-2032)

• Market Overview
• Needle-Free Injection Systems
• Oral Delivery Systems
• Nasal Delivery Systems
• Jet Injectors
• Microneedle Patches
• Microinjectors

Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Global Vaccine Delivery Devices Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Other End Users

Global Vaccine Delivery Devices Market Size & CAGR (2025-2032)

• North America (Type of Device, Route of Administration, End Users)
  • US
  • Canada
• Europe (Type of Device, Route of Administration, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Device, Route of Administration, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Device, Route of Administration, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Device, Route of Administration, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton Dickinson & Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxas (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corium International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations